OpenURL Connection Search

Select item for more details and to access through your institution.

Evaluation of Immunological Cross-Reactivity between Clade A9 High-Risk Human Papillomavirus Types on the Basis of E6-Specific CD4+ Memory T Cell Responses.
Published in:
Journal of Infectious Diseases, 2010, v. 202, n. 8, p. 1200, doi. 10.1086/656367
By:
- van den Hende, Muriel;
- Redeker, Anke;
- Kwappenberg, Kitty M. C.;
- Franken, Kees L. M. C.;
- Drijfhout, Jan W.;
- Oostendorp, Jaap;
- Valentijn, A. Rob P. M.;
- Fathers, Loraine M.;
- Welters, Marij J. P.;
- Melief, Cornelis J. M.;
- Kenter, Gemma G.;
- van der Burg, Sjoerd H.;
- Offringa, Rienk
Publication type:
Article
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.
Published in:
International Journal of Cancer, 2008, v. 123, n. 1, p. 146, doi. 10.1002/ijc.23502
By:
- van den Hende, Muriel;
- van Poelgeest, Mariëtte I.E.;
- van der Hulst, Jeanette M.;
- de Jong, Joan;
- Drijfhout, Jan W.;
- Fleuren, Gert Jan;
- Valentijn, A. Rob P.M.;
- Wafelman, Amon R.;
- Slappendel, Gijs M.;
- Melief, Cornelis J.M.;
- Offringa, Rienk;
- van der Burg, Sjoerd H.;
- Kenter, Gemma G.
Publication type:
Article
A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses.
Published in:
International Journal of Cancer, 2010, v. 126, n. 1, p. 133, doi. 10.1002/ijc.24804
By:
- Woo, Yin Ling;
- van den Hende, Muriel;
- Sterling, Jane C.;
- Coleman, Nicholas;
- Crawford, Robin A.F.;
- Kwappenberg, Kitty M.C.;
- Stanley, Margaret A.;
- van der Burg, Sjoerd H.
Publication type:
Article
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.
Published in:
Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-88
By:
- van Poelgeest, Mariette I. E.;
- Welters, Marij J. P.;
- van Esch, Edith M. G.;
- Stynenbosch, Linda F. M.;
- Kerpershoek, Gijs;
- van Persijn van Meerten, Els L.;
- den Hende, Muriel van;
- Löwik, Margriet J. G.;
- Berends-van der Meer, Dorien M. A.;
- Fathers, Lorraine M.;
- Valentijn, A. Rob P. M.;
- Oostendorp, Jaap;
- Fleuren, Gert Jan;
- Melief, Cornelis J. M.;
- Kenter, Gemma G.;
- van der Burg, Sjoerd H.
Publication type:
Article
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.
Published in:
2013
By:
- van Poelgeest, Mariette I E;
- Welters, Marij J P;
- van Esch, Edith M G;
- Stynenbosch, Linda F M;
- Kerpershoek, Gijs;
- van Persijn van Meerten, Els L;
- van den Hende, Muriel;
- Löwik, Margriet J G;
- Berends-van der Meer, Dorien M A;
- Fathers, Lorraine M;
- Valentijn, A Rob P M;
- Oostendorp, Jaap;
- Fleuren, Gert Jan;
- Melief, Cornelis J M;
- Kenter, Gemma G;
- van der Burg, Sjoerd H
Publication type:
journal article
Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer.
Published in:
2011
By:
- Scholten, Kirsten Bj;
- Turksma, Annelies W;
- Ruizendaal, Janneke J;
- van den Hende, Muriel;
- van der Burg, Sjoerd H;
- Heemskerk, Mirjam Hm;
- Meijer, Chris Jlm;
- Hooijberg, Erik;
- Scholten, Kirsten B J;
- Heemskerk, Mirjam H M;
- Meijer, Chris J L M
Publication type:
journal article

Found: 6

Evaluation of Immunological Cross-Reactivity between Clade A9 High-Risk Human Papillomavirus Types on the Basis of E6-Specific CD4+ Memory T Cell Responses.

Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.

A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses.

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer.